SNDX - Syndax Pharmaceuticals Q4 2022 Earnings Preview
- Syndax Pharmaceuticals ( NASDAQ: SNDX ) is scheduled to announce Q4 earnings results on Tuesday, February 28, after market close.
- The consensus EPS estimate is -$0.63 and the consensus revenue estimate is $0.43M (-99.7% Y/Y).
- Over the last 2 years, SNDX has beaten EPS estimates 100% of the time and has beaten revenue estimates 50% of the time.
For further details see:
Syndax Pharmaceuticals Q4 2022 Earnings Preview